Atopic Dermatitis
Conditions
Brief summary
The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.
Interventions
BEHAVIORALWeekly Internet survey
Parents will complete a weekly online survey about medication use.
DRUGTopical Triamcinolone
Topical triamcinolone to all affected areas once daily
Sponsors
Wake Forest University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
2 Years to 8 Years
Healthy volunteers
No
Inclusion criteria
* Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.
Exclusion criteria
* Child is less than 2 or greater than 8 years of age. * Known allergy or sensitivity to topical triamcinolone in the child. * Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access. * Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to topical triamcinolone | 12 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Eczema Area Severity Index | 12 weeks |
| Investigator's Global Assessment | 12 weeks |
Outcome results
None listed